The mitochondrial T1095C mutation increases gentamicin-mediated apoptosis

► Reduces mitochondrial anti-oxidant defenses. ► Increases apoptotic cell death in response to aminoglycoside treatment. ► Results in a 30% reduction in complex II/III activity compared to controls.